NCT02983448View on ClinicalTrials.gov

Noninvasive Neuromodulation to Reserve Diastolic Dysfunction

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

April 30, 2018

Conditions
Heart Failure, Diastolic
Interventions
DEVICE

transcutaneous vagus nerve stimulation

All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized

Trial Locations (1)

73104

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT02983448 - Noninvasive Neuromodulation to Reserve Diastolic Dysfunction | Biotech Hunter | Biotech Hunter